Sphera-Funds-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "NVMI",
  "MRUS",
  "ORIC",
  "NTR",
  "FROG",
  "ABBV",
  "APLS",
  "ARWR",
  "AVGO",
  "NICE",
  "NNDM",
  "SKYE",
  "SWTX",
  "TSEM",
  "RCKT",
  "ARVN",
  "ANNX",
  "ATXS",
  "GPCR",
  "IMTX",
  "CATX",
  "SVRA",
  "TVTX",
  "LRMR",
  "MLYS",
  "PHVS",
  "SNDX",
  "ALEC",
  "JANX",
  "APRE",
  "APLT",
  "AZN",
  "SRRK",
  "FATE",
  "AMAT",
  "JSPR",
  "META",
  "LVTX",
  null,
  "OTLK",
  "OKUR",
  "SEDG",
  "IONS",
  "PMN",
  "CYBN",
  null,
  "RZLT",
  "MRVL",
  "ACOG",
  "MSFT",
  "NVS",
  "TEVA",
  "ZURA",
  null,
  "NVDA",
  "PFE",
  "MRK",
  "AMGN",
  null,
  "ORA",
  null,
  "UBER",
  "RNA",
  "PRAX",
  "RGLS",
  "NTLA",
  "PERI",
  "COGT",
  "ETNB",
  "DYN",
  "SNY",
  "GSK",
  "SRPT",
  null,
  null,
  null,
  "CRVS",
  "CDTX",
  "ELDN",
  "ELEV",
  "ELVN",
  "INZY",
  "KURA",
  "KZR",
  "NVO",
  "AMZN",
  null,
  "VTYX",
  "VTGN",
  "VKTX",
  "VIR",
  "VIGL",
  "HOWL",
  "WIX",
  "WDAY",
  "XENE",
  "BIIB",
  "CHKP",
  "BHVN",
  "RARE",
  "CRM",
  "IMVT",
  "BMY",
  "BBIO",
  "CAMT",
  "CEVA",
  "CLDX",
  "DAWN",
  "CYTK",
  "NKE",
  "GOOG",
  "JNJ",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 114
Total Value: 419305182
Accession Number: 0001496201-25-000007
Form Type: 13F-HR
CIK: sphera-funds-management
Manager Name: Sphera-Funds-Management

Data Enrichment

92% identified

105 identified9 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

114 positions • $419.3M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 6

Sort by:

NOVARTIS AG

NVS|66987V109

Shares:50.0K

Value:$5.6M

% of Portfolio:1.3% ($5.6M/$419.3M)

Merck & Co., Inc.

MRK|58933Y105

Shares:59.6K

Value:$5.3M

% of Portfolio:1.3% ($5.3M/$419.3M)

686688AC6

Shares:5.0M

Value:$5.2M

% of Portfolio:1.2% ($5.2M/$419.3M)

NICE Ltd.

NICE|653656108

Shares:33.3K

Value:$5.1M

% of Portfolio:1.2% ($5.1M/$419.3M)

GSK plc

GSK|37733W204

Shares:130.0K

Value:$5.0M

% of Portfolio:1.2% ($5.0M/$419.3M)

SOLAREDGE TECHNOLOGIES, INC.

SEDG|83417M104

Shares:309.2K

Value:$5.0M

% of Portfolio:1.2% ($5.0M/$419.3M)

89bio, Inc.

ETNB|282559103

Shares:618.3K

Value:$4.5M

% of Portfolio:1.1% ($4.5M/$419.3M)

Merus N.V.

MRUS|N5749R100

Shares:106.5K

Value:$4.5M

% of Portfolio:1.1% ($4.5M/$419.3M)

Immatics N.V.

IMTX|N44445109

Shares:921.1K

Value:$4.2M

% of Portfolio:1.0% ($4.2M/$419.3M)

Apellis Pharmaceuticals, Inc.

APLS|03753U106

Shares:181.3K

Value:$4.0M

% of Portfolio:0.9% ($4.0M/$419.3M)

578784100

Shares:355.6K

Value:$3.9M

% of Portfolio:0.9% ($3.9M/$419.3M)

Praxis Precision Medicines, Inc.

PRAX|74006W207

Shares:100.0K

Value:$3.8M

% of Portfolio:0.9% ($3.8M/$419.3M)

Travere Therapeutics, Inc.

TVTX|89422G107

Shares:200.0K

Value:$3.6M

% of Portfolio:0.9% ($3.6M/$419.3M)

Savara Inc

SVRA|805111101

Shares:1.3M

Value:$3.6M

% of Portfolio:0.8% ($3.6M/$419.3M)

ARROWHEAD PHARMACEUTICALS, INC.

ARWR|04280A100

Shares:277.6K

Value:$3.5M

% of Portfolio:0.8% ($3.5M/$419.3M)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:329.3K

Value:$3.4M

% of Portfolio:0.8% ($3.4M/$419.3M)

Annexon, Inc.

ANNX|03589W102

Shares:1.8M

Value:$3.4M

% of Portfolio:0.8% ($3.4M/$419.3M)

Janux Therapeutics, Inc.

JANX|47103J105

Shares:125.8K

Value:$3.4M

% of Portfolio:0.8% ($3.4M/$419.3M)

CYBIN INC.

CYBN|23256X407

Shares:527.2K

Value:$3.3M

% of Portfolio:0.8% ($3.3M/$419.3M)

Immunovant, Inc.

IMVT|45258J102

Shares:194.6K

Value:$3.3M

% of Portfolio:0.8% ($3.3M/$419.3M)

Instrument	Shares		Other Manager	Value	% of Portfolio
NOVARTIS AG(NVScusip66987V109)	50.0K	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$5.6M	1.3% ($5.6M/$419.3M)	QoQ +14.56% (+$708.5K) YoY +15.24% (+$737.5K)
Merck & Co., Inc.(MRKcusip58933Y105)	59.6K	QoQ 0.00% (-0) YoY -42.47% (-44.0K)	All Managers (Combined)	$5.3M	1.3% ($5.3M/$419.3M)	QoQ -9.77% (-$579.3K) YoY -60.86% (-$8.3M)
(cusip686688AC6)✕	5.0M	QoQ 0.00% (+0) YoY NEW(+5.0M)	All Managers (Combined)	$5.2M	1.2% ($5.2M/$419.3M)	QoQ +4.22% (+$212.0K) YoY NEW(+$5.2M)
NICE Ltd.(NICEcusip653656108)	33.3K	QoQ -21.64% (-9.2K) YoY -61.22% (-52.6K)	All Managers (Combined)	$5.1M	1.2% ($5.1M/$419.3M)	QoQ -28.86% (-$2.1M) YoY -77.06% (-$17.2M)
GSK plc(GSKcusip37733W204)	130.0K	QoQ 0.00% (+0) YoY +30.00% (+30.0K)	All Managers (Combined)	$5.0M	1.2% ($5.0M/$419.3M)	QoQ +14.54% (+$639.6K) YoY +17.47% (+$749.2K)
SOLAREDGE TECHNOLOGIES, INC.(SEDGcusip83417M104)	309.2K	QoQ -17.54% (-65.8K) YoY +1053.79% (+282.4K)	All Managers (Combined)	$5.0M	1.2% ($5.0M/$419.3M)	QoQ -1.89% (-$96.9K) YoY +163.00% (+$3.1M)
89bio, Inc.(ETNBcusip282559103)	618.3K	QoQ +11.10% (+61.8K) YoY +19.86% (-102.5K)	All Managers (Combined)	$4.5M	1.1% ($4.5M/$419.3M)	QoQ +3.29% (+$143.3K) YoY -25.13% (-$1.5M)
Merus N.V.(MRUScusipN5749R100)	106.5K	QoQ -18.38% (-24.0K) YoY -28.66% (-42.8K)	All Managers (Combined)	$4.5M	1.1% ($4.5M/$419.3M)	QoQ -18.30% (-$1.0M) YoY -33.31% (-$2.2M)
Immatics N.V.(IMTXcusipN44445109)	921.1K	QoQ 0.00% (-0) YoY +38.28% (-255.0K)	All Managers (Combined)	$4.2M	1.0% ($4.2M/$419.3M)	QoQ -36.56% (-$2.4M) YoY -40.66% (-$2.8M)
Apellis Pharmaceuticals, Inc.(APLScusip03753U106)	181.3K	QoQ -12.07% (-24.9K) YoY NEW(+181.3K)	All Managers (Combined)	$4.0M	0.9% ($4.0M/$419.3M)	QoQ -39.73% (-$2.6M) YoY NEW(+$4.0M)
(cusip578784100)✕	355.6K	QoQ NEW(+355.6K) YoY NEW(+355.6K)	All Managers (Combined)	$3.9M	0.9% ($3.9M/$419.3M)	QoQ NEW(+$3.9M) YoY NEW(+$3.9M)
Praxis Precision Medicines, Inc.(PRAXcusip74006W207)	100.0K	QoQ +20.48% (-17.0K) YoY -43.54% (-77.1K)	All Managers (Combined)	$3.8M	0.9% ($3.8M/$419.3M)	QoQ -40.71% (-$2.6M) YoY -64.96% (-$7.0M)
Travere Therapeutics, Inc.(TVTXcusip89422G107)	200.0K	QoQ -9.37% (-20.7K) YoY NEW(+200.0K)	All Managers (Combined)	$3.6M	0.9% ($3.6M/$419.3M)	QoQ -6.77% (-$260.6K) YoY NEW(+$3.6M)
Savara Inc(SVRAcusip805111101)	1.3M	QoQ +5.99% (-72.6K) YoY NEW(+1.3M)	All Managers (Combined)	$3.6M	0.8% ($3.6M/$419.3M)	QoQ -4.36% (-$162.3K) YoY NEW(+$3.6M)
ARROWHEAD PHARMACEUTICALS, INC.(ARWRcusip04280A100)	277.6K	QoQ +40.49% (-80.0K) YoY NEW(+277.6K)	All Managers (Combined)	$3.5M	0.8% ($3.5M/$419.3M)	QoQ -4.79% (-$178.0K) YoY NEW(+$3.5M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	329.3K	QoQ +39.36% (-93.0K) YoY NEW(+329.3K)	All Managers (Combined)	$3.4M	0.8% ($3.4M/$419.3M)	QoQ -38.12% (-$2.1M) YoY NEW(+$3.4M)
Annexon, Inc.(ANNXcusip03589W102)	1.8M	QoQ +41.94% (-521.3K) YoY +15377.07% (+1.8M)	All Managers (Combined)	$3.4M	0.8% ($3.4M/$419.3M)	QoQ -46.59% (-$3.0M) YoY +4066.07% (+$3.3M)
Janux Therapeutics, Inc.(JANXcusip47103J105)	125.8K	QoQ +84.15% (-57.5K) YoY NEW(+125.8K)	All Managers (Combined)	$3.4M	0.8% ($3.4M/$419.3M)	QoQ -7.13% (-$260.9K) YoY NEW(+$3.4M)
CYBIN INC.(CYBNcusip23256X407)	527.2K	QoQ -2.02% (-10.9K) YoY NEW(+527.2K)	All Managers (Combined)	$3.3M	0.8% ($3.3M/$419.3M)	QoQ -29.57% (-$1.4M) YoY NEW(+$3.3M)
Immunovant, Inc.(IMVTcusip45258J102)	194.6K	QoQ NEW(+194.6K) YoY NEW(+194.6K)	All Managers (Combined)	$3.3M	0.8% ($3.3M/$419.3M)	QoQ NEW(+$3.3M) YoY NEW(+$3.3M)